SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Papa John's International, Inc. engages in the operation and franchise of pizza delivery and carryout restaurants. It operates through the following segments: Domestic Company-owned Restaurants, North America Franchising, North America Commissaries, International Operations, and All Others. The Domestic Company-Owned Restaurants segment consists of retail sales of pizza and side items, breadsticks, cheese sticks, chicken poppers and wings, dessert items, and canned and bottled beverages. The North America Franchising segment involves the offering of sales and support activities, development rights, and collection of royalties from franchisees located in the United States and Canada. The North America Commissaries segment includes the eleven full-service regional dough production and distribution and quality control centers. The International Operations segment represents all restaurant operations outside of the United States and Canada. The All Others segment focuses on franchise contributions to marketing funds and sale, company-owned and franchised restaurants, information systems and related services used in restaurant operations, point-of-sale system, online and other technology-based ordering platforms, printing, and promotional items. The company was founded by John H. Schnatter in 1984 and is headquartered in Louisville, KY.

Papa John`s International, Inc.

Take-private speculation is the dominant topic, centered on Irth Capitals reported bid and a major U.S. franchisee joining the effort; traders are debating whether a deal will materialize, with no confirmed agreement in the discussion. The takeover hopes contrast with criticism of management and concern over weak sales, a dividend suspension, and the stocks steep decline.

TOSHI

A burst of trading volume and a recent rebound have fueled talk of a technical breakout and a possible short squeeze in TOSHI, with many holders buying dips and anticipating a move through resistance. Others point to repeated failed breakouts, weak price action, and broader crypto-market softness; talk of an upcoming announcement or listing remains speculative.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

A sharp, news-unconfirmed XCN spike is driving attention, with traders reacting to a large candle and debating whether it marks a rebound or another brief pump-and-dump. Some are buying the dip and pointing to Bitcoins bounce, while skeptics say XCNs past spikes have quickly faded.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Amgens Phase 3 lung cancer results for IMDELLTRA plus AstraZenecas IMFINZI, which reduced the risk of death in first-line extensive-stage small cell lung cancer, are driving attention. Traders see the findings as a potential growth catalyst and debate how much they could expand the drugs commercial role alongside established products such as Repatha.

ProShares Trust II - ProShares Ultra Bloomberg Crude Oil 2x Shares

ProShares Ultra Bloomberg Crude Oil

Crudes rally amid escalating Middle East tensions and fears of disrupted oil supplies is driving attention to UCO. Traders are divided between following the bullish momentum and positioning for a pullback, with some noting that geopolitical headlines could quickly shift the oil trade.

Select Sector SPDR Trust (The) - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

XLE is drawing attention after reaching a new high as energy stocks outperform, with traders pointing to rising crude prices and supply risks tied to Middle East tensions and shipping disruptions. The conversation is broadly bullish on the breakout, though some traders warn the rally may be extended and question whether it can hold.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Mercks attention centers on Phase 3 results for its partnership with Moderna: the personalized cancer vaccine added to Keytruda reduced melanoma recurrence or death risk, drawing interest in the oncology platform and potential commercial upside. Traders debate whether the results justify further gains, given high expectations, unapproved status, and questions about manufacturing complexity and expansion beyond melanoma.

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

Celcuity Inc

Updated Phase 3 VIKTORIA-1 breast-cancer subgroup data presented at ESMO is drawing attention, with traders highlighting stronger progression-free survival and response results for gedatolisib combinations. Reactions are mixed: some see the findings as compelling, while others note the data builds on previously released topline results and say CELC still needs to demonstrate commercial uptake and revenue.

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

SHIB is drawing attention for choppy, largely sideways trading, with repeated technical posts describing consolidation and traders watching for a breakout. Holders are split between accumulating and anticipating a rebound, while skeptics point to weak momentum, limited utility, and the risk of further declines.

Anthropic

Anthropics anticipated blockbuster IPO is driving attention, with traders weighing rapid revenue growth against heavy compute commitments and reported losses. Some see a major AI-growth opportunity, while skeptics question whether the spending and intensifying competition can support the expected valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Philip Morris Reports Q3 Earnings: ETFs in Focus

Philip Morris delivered better-than-expected Q3 results, but geopolitical risks remain. Discover ETFs with significant exposure to the company.

Should You Invest in the iShares U.S. Consumer Staples ETF (IYK)?

Will PepsiCo's Q3 Turnaround Boost These ETFs?

PEP's Q3'26 earnings beat estimates, putting PEP-heavy ETFs in focus as investors weigh revenue growth against margin pressures and cost-cutting plans.

PEP Stock Looks To Snap 6-Week Losing Streak: Goldman Sachs Trims Price Target But Sees ‘Decade Of Growth’ For PepsiCo

Equity

PepsiCo faces near-term margin pressures from rising costs and beverage challenges, but Goldman Sachs maintains a ‘Buy’ rating.


Consumer Sentiment Drops in September: ETFs to Consider

Consumer sentiment falls to a four-month low amid persistent inflation and uncertainty. Here are some ETFs that investors may consider.

PEP Stock Heads For Worst Month Since May: PepsiCo Commits $1B To Colombia Expansion, Targets Higher Prices Ahead Of Q3 Earnings 

PepsiCo makes a $1 billion investment in Colombia amid pricing changes, weak North American sales, and upcoming third-quarter earnings. 


The Case for Increasing Portfolio Exposure to Consumer Staples ETFs

Weak consumer sentiment and rising economic risks could strengthen the case for consumer staples ETFs. Here are the funds worth considering now.

Coca-Cola's Momentum Builds After Strong Q2 Earnings: ETFs to Consider

Coca-Cola beat Q2 expectations, raised its guidance and got an extra lift from World Cup demand. Here are some ETFs that offer meaningful exposure.

KO Stock In Focus: Coca-Cola’s Fairlife Halts US Production After Ransomware Attack 

The disruption comes ahead of Q2 earnings, as investors assess recovery efforts, cyber risks and potential financial impact. 


iShares Trust - iShares U.S. Consumer Staples ETF

Neutral Sentiment

<ul class="summary-bullets"><li>Goldman Sachs cut its price target on PepsiCo to $165 from $180, still implying 28% upside.&nbsp;</li><li>The firm cited stronger quarterly sales and the consumer giant's decade-long growth potential.&nbsp;&nbsp;</li><li>PepsiCo plans cost cuts to fund beverage improvements and North American food investments.</li></ul>PepsiCo Inc. (PEP) is looking to reverse a six-week losing streak as Goldman Sachs maintains a ‘Buy’ rating despite cutting its price target. Stronger third-quarter (Q3) sales and decade-long growth potential support optimism, while rising costs, margin pressure, and beverage execution challenges weigh on near-term earnings.&nbsp;<a href="https://stocktwits.com/symbol/PEP">PepsiCo stock</a> edged 0.06% lower overnight on Thursday. The stock has gained nearly 2% so far this week.&nbsp;<h2 class="st-heading-2">Goldman Sachs Retains Buy Rating On PepsiCo&nbsp;</h2>Goldman Sachs analyst Bonnie Herzog lowered her price target on PepsiCo to $165 from $180 but reiterated her ‘Buy’ recommendation, implying a 28% upside to the stock’s last closing price. PepsiCo reported 3.1% organic sales growth in Q3, beating analysts' consensus estimate of 2.9%. Growth also rose from 2.4% in the previous quarter, an encouraging sign for the company's sales performance.&nbsp;Goldman Sachs sees room for PepsiCo to deliver average annual organic sales growth in the mid-single digits over the next decade. The firm's longer-term outlook suggests that the company could strengthen its growth path as it works through current business challenges.&nbsp;PepsiCo now&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/pepsi-co-tops-q3-estimates-as-international-growth-accelerates-cfo-sees-north-america-core-operating-margin-facing-pressure-in-q4/cZDUKgZRBNf">expects</a> organic sales growth of approximately 3% in fiscal 2026, narrowing its previous forecast of 2% to 4%. Management also&nbsp;slashed its outlook for constant-currency earnings per share growth to 1% to 2%, down from 4% to 6%, with growth previously expected near the lower end of that range.&nbsp;<h2 class="st-heading-2">PepsiCo CFO Flags Rising Costs&nbsp;</h2>During the Q3 earnings call, PepsiCo CFO Stephen Schmitt said the company is spending more to boost sales while facing higher costs, a weaker product sales mix, and execution issues.“Margin performance is below where we expected it to be. Input costs are trending higher and mix has been a headwind in particular.”Rather than pull back on spending, PepsiCo plans to continue funding important business initiatives. Schmitt said advertising and marketing expenditure has increased in both North America and international markets.&nbsp;CEO Ramon Laguarta said volume growth has fallen below the company's initial expectations, reflecting a challenging consumer environment and shortcomings in commercial execution.&nbsp;“Now we don't feel good about the beverage business. I think in the beverage business, as we put in our remarks, we're competing well in some platforms like hydration, like energy. We're not competing well in soft drinks. So we're putting all the urgency of the business and the focus in improving our performance in soft drinks.”PepsiCo is reviewing expenses across the organization, including corporate overhead and centrally allocated costs. Laguarta said the savings will help finance investments in beverages and North American food operations.&nbsp;<h2 class="st-heading-2">PEP Stock: Retail Stance&nbsp;</h2>On Stocktwits, retail sentiment around the stock slid to ‘bullish’ from ‘extremely bullish’.&nbsp;A user&nbsp;<a href="https://stocktwits.com/BlueBird7/message/666099073">said</a>, “Initiated a starter position today. Love the dividends.”Another user&nbsp;<a href="https://stocktwits.com/Strat58cat/message/666058012">said</a>, “The sell-off is based on strong earnings - and mid-to-high single-digit revenue growth - despite the current harsh environment. It's completely nonsensical. How low can it go, and for how long, while revenue grows because of tariffs and high energy prices? IDK. All I can do is buy low.”&nbsp;PEP stock has declined over 10% year-to-date.&nbsp;Also see:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/cathie-wood-s-ark-invest-adds-kratos-defense-aero-vironment-stocks-as-pentagon-bets-on-drones-to-drive-future-warfare/cZDUJ2aRBZw">Cathie Wood’s ARK Invest Adds Kratos Defense, AeroVironment Stocks As Pentagon Bets On Drones To Drive Future Warfare</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a hand holds a smartphone displaying the logo of PepsiCo, Inc.

PepsiCo Inc. (PEP) is looking to reverse a six-week losing streak as Goldman Sachs maintains a ‘Buy’ rating despite cutting its price target. Stronger third-quarter (Q3) sales and decade-long growth potential support optimism, while rising costs, margin p

iShares U.S. Consumer Staples ETF

PepsiCo Inc

Vanguard Consumer Staples ETF

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Fundamentals

Info

IYK iShares U.S. Consumer Staples ETF

Fundamentals

Latest IYK News